Clinical trial Recruiting at 5 sites Observational Ages 18 and up

TrueLok Elevate transverse bone transport for lower‑limb ulcers

Official title: Post-Market Clinical Follow-up Study of the TrueLok Elevate Transverse Bone Transport System for the Treatment of Lower Limb Ulcers as Soft Tissue Defects

Run by Orthofix s.r.l. · NCT07079774 · Data updated 2026-11-12

This project tests the TrueLok Elevate device in adults with chronic lower‑limb ulcers to see if controlled bone cuts and gradual distraction improve local blood flow and help wounds heal.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment153 (estimated)
SponsorOrthofix s.r.l.
Industry-sponsored
Locations14 sites (Halle and 13 other locations)
StatusRecruiting
StartedNovember 24, 2025
Main results expectedNovember 24, 2028
Study endsNovember 24, 2028
Registry record updatedSeptember 4, 2026
Trial IDNCT07079774 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with chronic lower‑limb ulcers present ≥3 months that have failed standard non‑surgical or surgical wound treatments and who are indicated for transverse bone transport surgery are the ideal candidates.

Probably not a fit

Patients who cannot adhere to postoperative care or follow‑up due to cognitive, behavioural, or other medical limitations, or those who respond to standard wound care or are not surgical candidates, are unlikely to benefit from this device.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational, multicenter registry of the TrueLok Elevate Transverse Bone Transport System used during indicated surgical care for adults with bony or soft‑tissue defects and chronic lower‑limb ulcers. The device uses a controlled corticotomy and slow transverse distraction to stimulate local vascularization and promote wound healing while patients receive standard postoperative follow‑up. Eligible patients have ulcers present for at least three months that have not responded to standard non‑surgical or surgical wound care. Data will be collected on wound healing, limb salvage, device performance, and safety across participating centers in Europe and South Africa.

Why it matters

Potential benefit: If successful, this approach could improve local blood flow and help stubborn lower‑limb ulcers close, potentially reducing the need for further surgery or amputation.

How similar studies have gone: Case series and small observational reports of transverse bone transport (including tibial transports) have reported improved wound healing and limb salvage in refractory lower‑limb ulcers, but randomized controlled data are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Aged 18 years or older at the time of surgery Willing and able to sign and date the study-specific informed consent form in accordance with national and institutional ethics requirements Willing and able to comply with requirements of the protocol, including follow-up requirements Indicated for surgical intervention using the TrueLok Elevate Transverse Bone Transport System for the treatment of soft tissue defects in the form of lower limb ulcers

Presence of a chronic ulcer, defined as:

* Present for at least 3 months, and
* Unresponsive to standard non-surgical or surgical wound management, including but not limited to debridement, negative pressure wound therapy (VAC), offloading, antibiotics, or vascular optimisation

Exclusion Criteria:

Mental or cognitive impairment or physiological or behavioural conditions that, in the opinion of the investigator, would preclude reliable adherence to postoperative care instructions, follow-up assessments, or study procedures

Known or presenting with the following signs of a systemic inflammatory response syndrome (SIRS) as exhibiting two or more of the following conditions:

o

* Heart rate \>90 beats/min
* Respiratory rate \>20 breaths/min
* PaCO2 \<32-mm Hg
* White blood cell count \>12.000 or \<4.000/cu mm
* 10% immature (band) forms Known hypersensitivity or allergy to any material used in the TrueLok Elevate Transverse Bone Transport System (e.g., stainless steel, titanium) Current participation in another interventional clinical study that, in the opinion of the investigator, may interfere with the objectives or outcomes of this study Presence of active malignancy or systemic infection that, in the investigator's opinion, may interfere with wound healing or the study protocol Life expectancy of less than 12 months Simultaneous bilateral application of the TrueLok Elevate Transverse Bone Transport System Current incarceration at the time of enrolment Any condition or clinical circumstance that, in the opinion of the investigator, would make participation not in the best interest of the subject or would interfere with the study objectives

Where it's running

  • Helios Klinikum Wuppertal GmbH
    Wuppertal, Germany
    Recruiting
  • Stellenbosch University
    Cape Town, Western Cape, South Africa
    Recruiting
  • Hospital de la Santa Creu i Sant Pau
    Barcelona, Spain
    Recruiting
  • Hospital Universitario Parc Taulí
    Barcelona, Spain
    Recruiting
  • Hull University Teaching Hospitals NHS Trust
    Hull, United Kingdom
    Recruiting
  • Universitätsklinikum Halle
    Halle, Germany
    Not yet recruiting
Show 8 more locations
  • Krankenhaus GmbH Landkreis Weilheim-Schongau
    Weilheim, Germany
    Not yet recruiting
  • General Regional Hospital F. Miulli of Acquaviva delle Fonti
    Acquaviva delle Fonti, Bari, Italy
    Active not recruiting
  • Azienda Ospedaliero Universitaria di Parma
    Parma, Pr, Italy
    Not yet recruiting
  • Sant'Andrea Hospital - University of Rome "La Sapienza"
    Roma, Rm, Italy
    Active not recruiting
  • San Giovanni Evangelista Hospital
    Tivoli, Rm, Italy
    Not yet recruiting
  • Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone
    Palermo, Italy
    Not yet recruiting
  • Fakultná nemocnica s poliklinikou Žilina
    Žilina, Slovakia
    Not yet recruiting
  • Newcastle's Royal Victoria Infirmary
    Newcastle upon Tyne, United Kingdom
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.